Published in
Taylor and Francis Group, Expert Review of Hematology, 9(13), p. 943-958, 2020
DOI: 10.1080/17474086.2020.1804356
Links
Tools
Immunomodulatory drug- and proteasome inhibitor-backbone regimens in the treatment of relapsed multiple myeloma: an evidence-based review
Journal article published in 2020 by
Larysa Sanchez 
,
Kevin Barley,
Joshua Richter,
Joseph Franz,
Hearn Jay Cho,
Sundar Jagannath,
Deepu Madduri,
Samir Parekh,
Shambavi Richard,
Ajai Chari
,
Kevin Barley,
Joshua Richter,
Joseph Franz,
Hearn Jay Cho,
Sundar Jagannath,
Deepu Madduri,
Samir Parekh,
Shambavi Richard,
Ajai Chari
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 